Fasting insulin is one of the most important — and most overlooked — metabolic biomarkers. It can detect insulin resistance 10 to 15 years before fasting glucose or HbA1c becomes abnormal, making it an essential early warning system for metabolic dysfunction that standard blood panels consistently miss.
When cells become resistant to insulin signaling, the pancreas compensates by producing more insulin to keep blood sugar levels normal. This means fasting glucose and HbA1c — the markers standard panels rely on — remain in the normal range while insulin levels quietly climb. By the time glucose-based markers flag a concern, the underlying metabolic pattern has been developing for over a decade.
Evidence-based optimal fasting insulin is between 2–6 µIU/mL. Standard lab reference ranges often consider up to 24.9 µIU/mL as normal — this threshold misses the vast majority of individuals with developing insulin resistance. HOMA-IR (calculated from fasting insulin and glucose) provides additional context: optimal is below 1.0.
Most standard metabolic panels only test fasting glucose and HbA1c. Fasting insulin is rarely ordered despite being a more sensitive early indicator of metabolic dysfunction. This means millions of people with developing insulin resistance go undetected until the pattern is well established.
Elevated fasting insulin is associated with increased risk of type 2 diabetes, cardiovascular disease, fatty liver disease, and metabolic syndrome. It often correlates with elevated hs-CRP (inflammation), elevated ApoB (cardiovascular risk), and metabolic dysfunction that may not be visible on standard blood work.
What is fasting insulin?
Fasting insulin measures the amount of insulin your pancreas produces in a fasting state. It is one of the earliest indicators of insulin resistance — detectable 10–15 years before fasting glucose becomes abnormal.
What is a good fasting insulin level?
Evidence-based optimal fasting insulin is 2–6 µIU/mL. Standard lab ranges often consider up to 24.9 µIU/mL as normal, which misses most developing insulin resistance.
Why doesn't my doctor test fasting insulin?
Most standard metabolic panels only test fasting glucose and HbA1c. Fasting insulin is rarely ordered despite being a more sensitive early indicator of metabolic dysfunction.
What is HOMA-IR?
HOMA-IR is a calculated score combining fasting insulin and fasting glucose to estimate insulin resistance severity. The formula is: (fasting insulin × fasting glucose) / 405. Optimal HOMA-IR is below 1.0.
Can insulin resistance be improved?
In many cases, insulin sensitivity can be meaningfully improved through nutrition, exercise, and lifestyle changes — particularly when patterns are identified early. Quarterly fasting insulin testing allows you to track whether your interventions are working.